🇺🇸 FDA

Intelligence Platform

Patents

Browse 5 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12419873

Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932617

Compound for use in retinal diseases

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11919896

[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11753377

Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11427581

JAK inhibitor and use thereof

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted